Life Sciences industry leader joins the region’s Life Science & Healthcare membership organisation
Cambridge, UK: 10 April 2024
At Cancer Research UK, we exist to beat cancer.
We are looking for 2 Senior Data Scientists to join our Marketing Fundraising and Engagement (MFE) directorate, enabling data driven decisions that drive impact.
At Cancer Research UK, we exist to beat cancer.
Cancer Research Horizons are seeking an experienced Scientist to provide lab‑based scientific leadership and intellectual input across the design, development, execution, and analysis of biochemical experiments. You will characterise target mechanisms, drive hit‑identification campaigns, generate high‑quality SAR/SKR data, and deliver compound mechanism‑of‑action studies. Your contributions will be central to shaping project strategy and advancing portfolio objectives.
Singleron Biotechnologies is an innovative life sciences tools company dedicated to applying groundbreaking single cell analysis techniques to research, clinical diagnosis, drug development, and health management. The company was incorporated in 2018 and currently has offices and laboratories in Germany, US, Singapore, and China.
Singleron is seeking motivated and ambitious talent in the field of single cell analysis and next generation sequencing as
Technical Sales Specialist– Single Cell Sequencing, UK
In this episode, host Sonjoy Brahma, VP of Clinical Operations at tranScrip, is joined by Joab Williamson of Faron Pharmaceuticals to explore the operational realities of working within small emerging biotech companies. They discuss the challenges of rare oncology development, how cash runway and clinical milestones shape strategy, and why flexibility, external expertise and careful planning are essential to balanced decision-making.
Peptide therapeutics offer highly specific and versatile treatments for complex and previously undruggable targets. High-throughput peptide library screening has accelerated discovery. However, traditional platforms such as phage or mRNA display are inherently limited by biological translation processes. DNA-encoded library (DEL) technology provides an alternative, enabling incorporation of unnatural amino acids and diverse cyclization strategies, and producing peptides with improved stability and prolonged retention.
Sandwich, UK — 25 March 2026: Discovery Park, Kent’s science and innovation hub, has launched the sixth edition of its Discovery Spark accelerator programme, welcoming 11 startups to its campus in Sandwich.
Amsbio announce the RPMotion – a spinning organoid bioreactor that facilitates fast, easy and efficient organoid culture for drug discovery, disease modelling and regenerative medicine.
LONDON, UK, March 18, 2026 / Biotech Newswire / -- Touchlight, in collaboration with New England Biolabs (NEB®), announces the launch of the EnClose™ Cell-free dbDNA™ Synthesis Kit, a new benchtop solution enabling rapid enzymatic production of Touchlight’s proprietary doggybone DNA™ (dbDNA™).
About Sygnature Discovery
At Sygnature Discovery, we create exceptional scientific outcomes. For our customers, who bring life-changing medicines to patients; and for our people, who help make this possible.
We’re 700+ scientists from over 50 countries, working as one across Europe and North America. With no competing internal programs, we offer total confidentiality and commitment.